In a recent move that signals confidence in the company he helps oversee, NexGel, Inc. (OTCMKTS:NXGL) Director Steven Mark Glassman has purchased shares of the company's common stock. The transaction, which took place on August 23, 2024, involved the acquisition of 10,000 shares at a price of $2.50 per share, totaling $25,000.
This purchase by Glassman is part of a registered direct offering by NexGel, a company known for its specialization in surgical and medical instruments and apparatus. Following the acquisition, Glassman now owns a total of 145,025 shares of common stock directly. Additionally, Glassman acquired warrants to purchase another 5,000 shares of common stock, although these warrants were obtained at no cost and are not part of the financial total for the transaction.
Investors might find the timing and the amount of the purchase noteworthy as it reflects a substantial investment by a key figure in the company. Glassman has agreed not to sell or otherwise dispose of the newly acquired shares or the shares underlying the warrants for a period of 180 days following the transaction date.
NexGel, previously known as AquaMed Technologies, Inc., operates out of Langhorne, PA, and has been incorporated in Delaware. The company's commitment to innovation in the medical field is reflected in its product offerings and strategic initiatives.
Such insider transactions are often closely watched by market participants as they can provide insights into the leadership's view of the company's future prospects. Glassman's purchase is a transaction that current and potential investors are likely to consider as they evaluate their positions in NexGel's stock.
In other recent news, hydrogel product specialist NEXGEL reported a 23.4% year-over-year increase in revenue for Q2 2024, reaching $1.44 million. This growth was primarily driven by the strong performance of its Silly George brand and the expansion of its manufacturing facility in Texas. However, the company reported a net loss of $979,000 for the quarter.
NEXGEL also completed a $1.11 million financing round and secured a supply agreement with Cintas Corporation (NASDAQ:CTAS), which is expected to contribute to future revenues. The firm's projections for Q3 and Q4 revenues stand at $2.2 million and $2.6 million, respectively.
In addition, NEXGEL anticipates a revenue boost in the second half of the year, largely driven by its consumer products. The company expects to see revenue from its partnership with AbbVie (NYSE:ABBV) starting in Q1 2025. Despite the net loss for Q2, the company remains optimistic about its financial performance in the upcoming quarters.
InvestingPro Insights
In light of the recent insider stock purchase by NexGel, Inc. (OTCMKTS:NXGL) Director Steven Mark Glassman, a deeper dive into the company's financial health and market performance using InvestingPro insights could provide additional context for investors. NexGel's market capitalization stands at approximately $18.95 million, reflecting the company's current valuation in the market. Despite a notable revenue growth of 74.04% over the last twelve months as of Q2 2024, it's important to acknowledge the company's challenges, as highlighted by InvestingPro Tips.
One of the InvestingPro Tips suggests that NexGel is quickly burning through cash, which could be a concern for investors looking for financial stability. Additionally, analysts do not anticipate NexGel will be profitable this year, which aligns with the company's negative P/E ratio of -4.61, further adjusted to -5.27 for the last twelve months as of Q2 2024. This metric indicates that the company is not generating earnings at the moment, which could be a red flag for investors seeking positive earnings growth.
However, it's not all cautionary news. NexGel has demonstrated a strong return over the last three months, with a price total return of 29.05%. This could signal a positive market sentiment or reaction to recent developments within the company. It's also worth noting that NexGel operates with a moderate level of debt, which could suggest a balanced approach to leveraging and growth. For investors interested in NexGel's potential and insider confidence, these insights might offer a mixed bag of opportunities and risks.
For a more comprehensive analysis and additional InvestingPro Tips for NexGel, investors can explore further insights on Investing.com, where several other tips are available to help make informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.